POINT: Should an Attempt Be Made to Withdraw Inhaled Corticosteroids in All Patients With Stable GOLD 3 (30% ≤ FEV <50% Predicted) COPD? Yes

James D. Chalmers

doi:10.1016/j.chest.2018.01.029

POINT: Should an Attempt Be Made to Withdraw Inhaled Corticosteroids in All Patients With Stable GOLD 3 (30% ≤ FEV <50% Predicted) COPD? Yes

James D. Chalmers (Lead / Corresponding author)

Molecular and Clinical Medicine

Research output: Contribution to journal › Editorial › peer-review

5 Citations (Scopus)

Original language	English
Pages (from-to)	778-782
Number of pages	5
Journal	Chest
Volume	153
Issue number	4
Early online date	21 Feb 2018
DOIs	https://doi.org/10.1016/j.chest.2018.01.029
Publication status	Published - Apr 2018

Access to Document

10.1016/j.chest.2018.01.029Licence: Elsevier User Licence

Link to publication in Scopus

Cite this

@article{154e225462004ff2b37a83360c0a3f5b,

title = "POINT: Should an Attempt Be Made to Withdraw Inhaled Corticosteroids in All Patients With Stable GOLD 3 (30% ≤ FEV <50% Predicted) COPD? Yes",

author = "Chalmers, {James D.}",

note = "J. D. C. reports research grants from GlaxoSmithKline, Boehringer-Ingelheim, AstraZeneca, and Pfizer.",

year = "2018",

month = apr,

doi = "10.1016/j.chest.2018.01.029",

language = "English",

volume = "153",

pages = "778--782",

journal = "Chest",

issn = "0012-3692",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - POINT

T2 - Should an Attempt Be Made to Withdraw Inhaled Corticosteroids in All Patients With Stable GOLD 3 (30% ≤ FEV <50% Predicted) COPD? Yes

AU - Chalmers, James D.

N1 - J. D. C. reports research grants from GlaxoSmithKline, Boehringer-Ingelheim, AstraZeneca, and Pfizer.

PY - 2018/4

Y1 - 2018/4

UR - http://www.scopus.com/inward/record.url?scp=85044144928&partnerID=8YFLogxK

U2 - 10.1016/j.chest.2018.01.029

DO - 10.1016/j.chest.2018.01.029

M3 - Editorial

C2 - 29474807

VL - 153

SP - 778

EP - 782

JO - Chest

JF - Chest

SN - 0012-3692

IS - 4

ER -